Trials / Completed
CompletedNCT06625840
A Study of MK-1167 in Healthy Elderly Participants (MK-1167-004)
A Randomized, Double-Blind Clinical Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MK-1167 in Healthy Elderly Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 60 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to learn how safe MK-1167 is in healthy elderly adults and how well people tolerate it.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-1167 | Oral Administration |
| DRUG | Placebo | Oral Administration |
Timeline
- Start date
- 2023-09-18
- Primary completion
- 2024-05-08
- Completion
- 2024-05-08
- First posted
- 2024-10-03
- Last updated
- 2024-10-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06625840. Inclusion in this directory is not an endorsement.